Biogen Inc. stock falls Wednesday, underperforms market

Shares of Biogen Inc.

slipped 3.49% to $278.98 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index

rising 0.28% to 4,147.60 and the Dow Jones Industrial Average

rising 0.11% to 34,128.05. This was the stock’s second consecutive day of losses. Biogen Inc. closed $32.90 below its 52-week high ($311.88), which the company reached on November 30th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson

fell 1.65% to $159.37 and Pfizer Inc.

fell 0.91% to $43.32. Trading volume (1.6 M) eclipsed its 50-day average volume of 1.1 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.